GlassScriptPhysician profile
Lucas First
NPI 1558892893
$1,360.40
in general payments reported to CMS, 2019-2025
20 companies · $166 in 2025
The $166 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $172 · 2023: $537 · 2024: $485 · 2025: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,188.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,188.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $469.18 | 2022-2025 | Sprint Pns System |
| Boston Scientific Corporation | $283.51 | 2022-2024 | |
| Saluda Medical Americas, INC. | $116.95 | 2024 | Evoke |
| Zimmer Biomet Holdings, INC. | $89.41 | 2023-2025 | Neuro Plating System |
| Ipsen Biopharmaceuticals, INC | $49.95 | 2024-2025 | Dysport |
| Abbott Laboratories | $37.55 | 2023-2024 | Proclaim, Eterna |
| Relievant Medsystems, INC. | $35.04 | 2022 | |
| Integra Lifesciences Corporation | $32.94 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Abbvie INC. | $28.71 | 2024 | |
| Vertos Medical, INC. | $27.20 | 2023 | Mild Device Kit |
| Azurity Pharmaceuticals, INC. | $26.30 | 2023 | Gliadel |
| Astrazeneca Pharmaceuticals LP | $23.19 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $23.16 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $22.72 | 2023 | Seglentis |
| Endo USA, INC. | $19.73 | 2025 | Xiaflex |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $16.86 | 2023 | |
| Avanos Medical | $16.25 | 2025 | |
| Janssen Pharmaceuticals, INC | $14.27 | 2023 | Xarelto |
| Scilex Pharmaceuticals INC. | $14.10 | 2025 | |
| Stratus Medical, LLC | $13.38 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lucas First listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.